`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`JUNIPER NETWORKS, INC.
`Petitioner
`
`v.
`
`IMPLICIT, LLC
`Patent Owner
`
`Case: IPR2020-00587
`Patent No. 9,591,104
`
`
`
`
`
`
`
`
`
`SUR-REPLY IN RESPONSE TO PETITION FOR INTER PARTES
`REVIEW OF U.S. PATENT NO. 9,591,104
`
`
`
`
`
`
`
`
`
`TABLE OF CONTENTS
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Table of Authorities .................................................................................................. ii
`
`I.
`
`
`
`
`
`The Petition Relies on the Same Prior Art—Decasper ......................... 1
`
`The Petition Relies on Substantially the Same Prior Art—CheckPoint
`and Smith .............................................................................................. 2
`
`The First Prong of Advanced Bionics Applies ................................................ 1
`
`A.
`
`B.
`
`
`
`
`C.
`
`The Petition Presents Substantially the Same Arguments That Were
`Before the Patent Office ........................................................................ 3
`
`Juniper Has Not Demonstrated That the Patent Office Erred ......................... 5
`
`
`II.
`
`III. Conclusion ....................................................................................................... 7
`
`
`
`
`
`
`i
`
`
`
`
`
`TABLE OF AUTHORITIES
`
`
`Cases
`
`Acceleration Bay, LLC v. Activision Blizzard, Inc.,
`
`908 F.3d 765 (Fed. Cir. 2018) ......................................................................... 6
`
`Advanced Bionics, LLC v. MED-EL Elektromedizinische Geräte GmbH
`
`IPR2019-01469, Paper 6 (PTAB Dec. Feb. 13, 2020) .................................... 1
`
`Becton, Dickinson & Co. v. B. Braun Melsungen AG
`
`IPR2017-01586, Paper 8 (PTAB Dec. 15, 2017) ............................................ 5
`
`Colas Sols., Inc. v. Blacklidge Emulsions, Inc.,
`759 F. App’x 986 (Fed. Cir. 2019) (non-precedential) ................................... 6
`
`
`Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd.,
`
`821 F.3d 1359 (Fed. Cir. 2016) ....................................................................... 6
`
`
`Statutes
`
`35 U.S.C. § 325(d) ..................................................................................................... 1
`
`
`
`
`
`
`
`ii
`
`
`
`
`
`Juniper fails to show that the Board should institute proceedings. It is
`
`undisputed that the Patent Office considered Decasper in detail and allowed the
`
`claims. That reality—which Juniper did not address in Reply—weighs heavily
`
`against instituting proceedings under the first prong of Advanced Bionics. Juniper
`
`also conceded in its Petition that it did not seek reversal of any alleged error made
`
`during prosecution. Pet. at 15. That forecloses additional review under the second
`
`prong of Advanced Bionics. And it ends the inquiry under Section 325(d).
`
`In Reply, Juniper focuses on two different references—CheckPoint and
`
`Smith—as providing a reason to institute proceedings. But Juniper only relies on
`
`those references for disclosure of supposed “trivial ‘TCP’ limitations,” Reply, at 1.
`
`And, for that disclosure, these references are the same in substance as what the Patent
`
`Office already considered during prosecution when it allowed these claims. And,
`
`again, Juniper did not allege in its Petition that the Patent Office erred. Section
`
`325(d) forecloses further review.
`
`I.
`
`The First Prong of Advanced Bionics Applies
`
`A. The Petition Relies on the Same Prior Art—Decasper
`
`It is undisputed that (1) both grounds in the Petition are based on the Decasper
`
`reference and (2) the Decasper reference was front-and-center during prosecution of
`
`the Implicit Patents. Juniper does not contest those facts. It instead flips around the
`
`references to call CheckPoint and Smith (and not Decasper) the “primary”
`
`
`
`1
`
`
`
`
`
`references. But Juniper’s Reply exposes that mislabeling: Juniper relies on
`
`CheckPoint and Smith for the supposed “trivial ‘TCP’ limitations” of the claims,
`
`Reply, at 1, while it relies on Decasper’s teaching for every other limitation (e.g.,
`
`receiving packets of a message, creating a path, storing the path, processing
`
`subsequent packets using the path, etc…).
`
`Decasper is the primary reference for both of Juniper’s proposed grounds.
`
`The Patent Office considered that reference, and Implicit addressed that reference in
`
`detail during prosecution. This weighs against instituting proceedings here.
`
`B.
`
`The Petition Relies on Substantially the Same Prior Art—
`CheckPoint and Smith
`
`CheckPoint and Smith were also before the Patent Office in substance (and,
`
`in the case of CheckPoint, by name). With regard to CheckPoint, Juniper does not
`
`dispute that two CheckPoint references were before the Patent Office during
`
`prosecution. Juniper also does not contend that, for the issues in its Petition, the
`
`substance in its “new” CheckPoint reference is different from the prior CheckPoint
`
`references. See Reply, at 5.
`
`Juniper instead points to different words from the new CheckPoint reference,
`
`specifically “application-layer ‘Security Server’” and the “Content Vectoring
`
`Protocol (CVP).” Reply, at 5. These different words, however, do not change the
`
`analysis. Juniper relies on those disclosures for their alleged application-layer
`
`processing. See Pet. at 54–57. That is the same supposed teaching reproduced in
`
`
`
`2
`
`
`
`
`
`the dozen-plus instances from the two prior CheckPoint references that Implicit cited
`
`in its Response. See Resp. at 10–12. And, critically, Juniper does not contest that
`
`fact in Reply. It does not allege that either of these “new” disclosures from
`
`CheckPoint are different in substance from what the prior references already
`
`disclosed. That weighs against institution.
`
`The same is true for Smith. Juniper asserts that Smith contains new subject
`
`matter because it is at an “endpoint of [two] TCP connections” and contains a
`
`“Caching Web Documents” feature that uses HTTP. Reply, at 4. But that subject
`
`matter was before the Patent Office in other references. Those references disclose
`
`gateways that can operate as endpoints. See, e.g., Ex. 2011, at 163 (depicting
`
`gateway as endpoint for communications with Computer A and Computer B); Ex.
`
`2012, at 16 (“[O]ur approach towards performing QoS control was an end-to-end
`
`solution, i.e., adaptation was achieved at the end points of a video conferencing
`
`session.”). They also disclose the use of HTTP. See, e.g., Resp. at 11–12 (collecting
`
`citations to CheckPoint references, including HTTP). And, like its new CheckPoint
`
`reference, Juniper does not explain how Smith is materially different than what the
`
`Patent Office considered during prosecution. Because Smith and CheckPoint are at
`
`most cumulative, the first prong of Advanced Bionics is satisfied.
`
`C. The Petition Presents Substantially the Same Arguments
`That Were Before the Patent Office
`
`Juniper’s Petition presents the same subject matter that the Patent Office
`
`
`
`3
`
`
`
`
`
`considered during prosecution. That satisfies the first prong of Advanced Bionics.
`
`In addition, substantially the same arguments were before the Patent Office. During
`
`reexamination of the Implicit Patent family, Juniper made the same arguments
`
`regarding Decasper that it makes here, namely that Decasper could be implemented
`
`in a firewall or gateway. See, e.g., Resp. at 16–17 (citing instances in which Juniper
`
`asserted that “Decasper98 teaches ‘a firewall plugin’” and “Decasper98 teaches an
`
`architecture that is ‘very well suited to Application Layer Gateways . . . and to
`
`security devices like Firewalls’”). Juniper does not contest that fact in Reply.
`
`Juniper instead ignores these statements. It contends that its arguments for
`
`Smith are new because there allegedly was not “any consideration of how the
`
`Decasper framework would be beneficially incorporated into this type of ALG.”
`
`Reply, at 4 (emphasis added). But Juniper’s own Petition shows that this position is
`
`wrong: the Petition relies on the exact same disclosure as above to assert a
`
`motivation to combine Decasper with Smith. Pet. at 20 (“As detailed below, it was
`
`obvious to apply Decasper to Smith, particularly since Decasper explains that its
`
`“framework is also very well suited to Application Layer Gateways (ALGs), and to
`
`security devices like Firewalls.”) (emphases in original).
`
`Juniper also argues that the Board should ignore its prior arguments regarding
`
`CheckPoint because those arguments related to “different limitations.” Reply, at 4.
`
`That misses the point. During prosecution of the Implicit Patents, Implicit
`
`
`
`4
`
`
`
`
`
`specifically pointed the Examiner to the reexamination record of the Implicit Patent
`
`family, disclosed the CheckPoint references, and amended the claims to add the
`
`limitations requiring executing TCP and converting packets from TCP to another
`
`format (such as an application-level format). If that functionality were “trivial,” the
`
`Examiner had the material to make the rejection, including Juniper’s arguments
`
`about CheckPoint and Decasper. The Examiner declined to do so, and allowed the
`
`claims. Juniper disagrees and recycles those arguments in its Petition. But it is not
`
`the purpose of Inter Partes Review to second guess the Examiner’s decision. Thus,
`
`under either route, the first prong of Advanced Bionics is satisfied in this case.
`
`II.
`
`Juniper Has Not Demonstrated That the Patent Office Erred
`
`Juniper has not demonstrated error. Indeed, Juniper’s Petition conceded that
`
`it was not basing its Petition on an error. It asserted that the error during examination
`
`factor (Becton, Dickinson factor (e)) “do[es] not apply in the instant action”:
`
`the examiner’s
`Although Petitioner disagrees with
`apparent finding that Decasper fails to disclose the added
`TCP limitations, this Petition does not rely on a reversal of
`any such finding. Instead, the challenge here uses other
`references for the allegedly missing limitation. Hence,
`these two [Becton, Dickinson] factors [(e) and (f)] do not
`apply in the instant action.
`
`Pet. at 15. Juniper also did not point to new evidence in its Petition as justifying
`
`review, other than the “other references” its presented besides Decasper (i.e.,
`
`CheckPoint and Smith).
`
`
`
`5
`
`
`
`
`
`Juniper then changed positions in Reply. It now asserts that the Examiner
`
`committed “material error,” including its decision to “not challenge Implicit’s
`
`mischaracterization of Decasper as limited to an IP router implementation.” Reply,
`
`at 6. It points to its “detailed expert evidence” as supporting review. Id. at 7.
`
`None of those positions were in Juniper’s Petition, and, for that reason,
`
`Juniper has waived them. See, e.g., Intelligent Bio-Systems, Inc. v. Illumina
`
`Cambridge Ltd., 821 F.3d 1359, 1369–70 (Fed. Cir. 2016) (finding that Board
`
`properly excluded Reply Brief under 37 C.F.R. § 42.23(b) where the Brief raised an
`
`“entirely new rationale” that was not raised in the Petition); Acceleration Bay, LLC
`
`v. Activision Blizzard, Inc., 908 F.3d 765, 775 (Fed. Cir. 2018) (finding that the
`
`Board properly excluded new argument in Reply that was “not made in the petition,”
`
`even though the petition “had an opportunity to present this argument in its petition,
`
`but chose not to”); Colas Sols., Inc. v. Blacklidge Emulsions, Inc., 759 F. App’x 986,
`
`990 (Fed. Cir. 2019) (non-precedential) (upholding Board’s exclusion of theory
`
`raised in Reply brief where the Petitioner “fail[ed] to point to a single line of its
`
`original Petition articulating this theory”). Because Juniper did not demonstrate
`
`error in its Petition—and, in fact, conceded the point—Juniper has not carried its
`
`burden on this factor.
`
`Juniper’s new arguments in Reply are also wrong on the merits. The
`
`Examiner did not overlook art or arguments. Implicit addressed Decasper in detail
`
`
`
`6
`
`
`
`
`
`and specifically pointed the examiner to the reexamination file histories (in which
`
`Decasper rendered claims unpatentable and contain the same arguments that Juniper
`
`makes here). Implicit submitted the relevant prior art subject matter that Juniper
`
`recycles in its Petition. Implicit amended the claims to add the TCP-related
`
`limitations and explained, in detail, why the claims were patentable. The Examiner
`
`had the art and arguments to make the rejections that Juniper now requests, and
`
`Decasper was front-and-center. The Examiner decided to allow the claims.
`
`Juniper has not demonstrated an error during prosecution that warrants re-
`
`plowing the same ground. It has not pointed to any particular error in the Examiner’s
`
`findings. It has not provided new prior art subject matter to demonstrate an error.
`
`And it has not pointed to any arguments or evidence beyond what was already in
`
`front of the Office during examination via the reexamination history, viz., that
`
`Decasper “teaches ‘a firewall plugin’” and teaches “architecture that is ‘very well
`
`suited to Application Layer Gateways . . . and to security devices like Firewalls.”
`
`Juniper may believe the Examiner’s decision is incorrect. But that is insufficient to
`
`meet Juniper’s burden under the second prong of Advanced Bionics.
`
`III. CONCLUSION
`
`For the reasons set forth above, Patent Owner respectfully requests that the
`
`Board decline to institute proceedings in this case under Section 325(d).
`
`
`
`
`
`
`
`7
`
`
`
`
`
`Dated: June 23, 2020
`
`
`
`
`
`Respectfully submitted,
`
`DAVIS FIRM, PC
`
`By:/s/Christian J. Hurt
`Christian J. Hurt
`
`8
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF COMPLIANCE
`
`I hereby certify that the foregoing Preliminary Response complies with the
`
`type-volume limitation and general format requirements pursuant to 37 C.F.R.
`
`§§42.24 and 42.6. I further certify that this response contains seven pages or less
`
`per the Board’s Order, excluding parts exempted by 37 C.F.R. §42.24.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/Christian J. Hurt
`Christian J. Hurt
`
`
`
`9
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on June 23, 2020, a true copy of the following
`
`document(s):
`
`PATENT OWNER IMPLICIT, LLC’S SUR-REPLY PETITION FOR
`INTER PARTES REVIEW OF U.S. PATENT NO. 9,591,104
`was served as follows:
`
`Rory P. Shea
`shea@ls3ip.com
`Cole B. Richter
`richter@ls3ip.com
`George I. Lee
`lee@ls3ip.com
`Michael P. Boyea
`boyea@ls3ip.com
`Lee Sullivan Shea & Smith LLP
`224 North Desplaines Street, Suite 250
`Chicago, IL 60661
`
`
`I declare under penalty of perjury under the laws of the United States of
`
`America that the foregoing is true and correct. Executed on June 23, 2020 at
`
`Dallas, Texas.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/Christian J. Hurt
`Christian J. Hurt
`
`10
`
`